These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15902566)

  • 1. Absolute configuration of N-acetylaspartate in urine from patients with Canavan disease.
    Bal D; Gryff-Keller A; Gradowska W
    J Inherit Metab Dis; 2005; 28(4):607-9. PubMed ID: 15902566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild elevation of N-acetylaspartic acid and macrocephaly: diagnostic problem.
    Surendran S; Bamforth FJ; Chan A; Tyring SK; Goodman SI; Matalon R
    J Child Neurol; 2003 Nov; 18(11):809-12. PubMed ID: 14696913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease.
    Matalon R; Michals K; Sebesta D; Deanching M; Gashkoff P; Casanova J
    Am J Med Genet; 1988 Feb; 29(2):463-71. PubMed ID: 3354621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New T530C mutation in the aspartoacylase gene caused Canavan disease with no correlation between severity and N-acetylaspartate excretion.
    Di Pietro V; Cavallari U; Amorini AM; Lazzarino G; Longo S; Poggiani C; Cavalli P; Tavazzi B
    Clin Biochem; 2013 Dec; 46(18):1902-4. PubMed ID: 24036223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Canavan disease or N-acetyl aspartic aciduria: a case report].
    Boughamoura L; Chaabane F; Tilouche S; Chabchoub I; Kabachi N; Tlili K; Yacoub M; Essoussi AS
    Arch Pediatr; 2007 Feb; 14(2):173-6. PubMed ID: 17196380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of the 1H and 13C NMR spectra of N-acetylaspartylglutamate and its detection in urine from patients with Canavan disease.
    Krawczyk H; Gradowska W
    J Pharm Biomed Anal; 2003 Mar; 31(3):455-63. PubMed ID: 12615232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canavan disease: diagnosis and molecular analysis.
    Matalon R
    Genet Test; 1997; 1(1):21-5. PubMed ID: 10464621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fast 1H NMR spectroscopy procedure for quantitative determination of N-acetylaspartate in urine samples.
    Pinheiro GM; Basso EA; Fiorin BC; Cendes F; Rittner R; Oliveira AN; Höehr NF
    Clin Chim Acta; 2009 Jun; 404(2):166-8. PubMed ID: 19298803
    [No Abstract]   [Full Text] [Related]  

  • 9. Atypical clinical and radiological course of a patient with Canavan disease.
    Sarret C; Boespflug-Tanguy O; Rodriguez D
    Metab Brain Dis; 2016 Apr; 31(2):475-9. PubMed ID: 26586007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid and sensitive screening for and chemical diagnosis of Canavan disease by gas chromatography-mass spectrometry.
    Inoue Y; Kuhara T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 806(1):33-9. PubMed ID: 15149608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of N-acetylaspartic acid in urine by LC-MS/MS for the diagnosis of Canavan disease.
    Al-Dirbashi OY; Rashed MS; Al-Qahtani K; Al-Mokhadab MA; Kurdi W; Al-Sayed MA
    J Inherit Metab Dis; 2007 Aug; 30(4):612. PubMed ID: 17632691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.
    Francis JS; Wojtas I; Markov V; Gray SJ; McCown TJ; Samulski RJ; Bilaniuk LT; Wang DJ; De Vivo DC; Janson CG; Leone P
    Neurobiol Dis; 2016 Dec; 96():323-334. PubMed ID: 27717881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis of Canavan syndrome: how can we get there?
    De Bernardo G; Giordano M; Sordino D; Buono S
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26245283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative measurements with localized 1H MR spectroscopy in children with Canavan's disease.
    Wittsack HJ; Kugel H; Roth B; Heindel W
    J Magn Reson Imaging; 1996; 6(6):889-93. PubMed ID: 8956134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of Canavan disease: the first biochemically proven case in a Japanese girl.
    Hamaguchi H; Nihei K; Nakamoto N; Ezoe T; Naito H; Hara M; Yokota K; Inoue Y; Matsumoto I
    Brain Dev; 1993; 15(5):367-71. PubMed ID: 8279652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of localized proton nuclear magnetic resonance spectroscopy in Canavan's disease.
    Aydinli N; Calişkan M; Calay M; Ozmen M
    Turk J Pediatr; 1998; 40(4):549-57. PubMed ID: 10028864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease.
    Divry P; Mathieu M
    Am J Med Genet; 1989 Apr; 32(4):550-1. PubMed ID: 2774002
    [No Abstract]   [Full Text] [Related]  

  • 18. Prenatal detection of Canavan disease (aspartoacylase deficiency) by DNA analysis.
    Elpeleg ON; Shaag A; Anikster Y; Jakobs C
    J Inherit Metab Dis; 1994; 17(6):664-6. PubMed ID: 7707689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Megalencephaly with dystonia revealing Canavan disease].
    Maaloul I; Fourati H; Wali M; Chabchoub I; Kamoun T; Mnif Z; Kaabachi N; Hachicha M
    Arch Pediatr; 2013 Jul; 20(7):783-6. PubMed ID: 23727372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical MRI findings in Canavan disease: a patient with a mild course.
    Yalcinkaya C; Benbir G; Salomons GS; Karaarslan E; Rolland MO; Jakobs C; van der Knaap MS
    Neuropediatrics; 2005 Oct; 36(5):336-9. PubMed ID: 16217711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.